Hesperetin attenuates neuroprotective effect against 3-Nitropropionic acid induced Huntington’s disease-like behavioral symptoms in rats
Abstract
The disease Huntington’s (HD) is an autosomal neurologic disorder characterized by inexorable loss of nerve cells in the brain accompanied with cognitive, motor and psychiatric disorders. In the present study, 3-Nitropropionic acid (3-NP), an inhibitor of mitochondrial citric acid cycle results in symptoms like HD. Hesperetin(HSP) is a flavanone rich in citrus species which possess neuroprotective effects. The aim of the present study was to evaluate the protective role of HSP against 3-NP induced symptoms. Pre-treatment of animals with HSP/normal saline for 7 days and from 8th day, 3-NP (10mg/kg) was co-administered with HSP. It is continued for 21 days of the treatment schedule. At the end day of the study, the results showed that HSP improved all the cognitive, motor and psychiatric symptoms induced by 3-NP significantly. Hence, these findings show the protective effect of HSP against 3-NP induced neurological disorder.
Keywords: Huntington’s disease, Hesperetin, 3-Nitropropionic acid,
Keywords:
Huntington’s disease, Hesperetin, 3-Nitropropionic acidDOI
https://doi.org/10.22270/jddt.v14i11.6823References
1. Leegwater-Kim J, Cha JJ, The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration, NeuroRx, 2004:128-138. https://doi.org/10.1602/neurorx.1.1.128 PMid:15717013 PMCid:PMC534918
2. Wang LH, Qin ZH, Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin 2006; 27:1287-1302. https://doi.org/10.1111/j.1745-7254.2006.00410.x PMid:17007735
3. Garcia M, Vanhoutte P, Pages C, et al, The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module, J Neurosci, 2002; 22: 2174-2184. https://doi.org/10.1523/JNEUROSCI.22-06-02174.2002 PMid:11896157 PMCid:PMC6758250
4. Tunez I, Inmaculada T, Perez-De LCV, Santamaria A, 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future, Molecules, 2008;15: 878-916. https://doi.org/10.3390/molecules15020878 PMid:20335954 PMCid:PMC6263191
5. Wang M, Tsao R, Zhang S, et al, Antioxidant activity, mutagenicity/ anti-mutagenicity, and clastogenicity/anti-clastogenicity of lutein from marigold flowers, Food Chem Toxicol, 2006; 54: 7998-8005. https://doi.org/10.1016/j.fct.2006.04.005 PMid:16757077
6. Schulz JB, Matthews RT, Henshaw DR, Beal MF, Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases, Neuroscience, 1996; 71: 1043-1048 https://doi.org/10.1016/0306-4522(95)00527-7 PMid:8684608
7. Tariq M, Khan HA, Elfaki I, Deeb SA, Moutaery KA, Neuroprotective effect of nicotine against 3-nitropropionic acid induced experimental Huntington's disease in rats, Brain. Res. Bull, 2005; 67: 161-168. https://doi.org/10.1016/j.brainresbull.2005.06.024 PMid:16140176
8. Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, Borstel RW, Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res, 2003; 994:44-54. https://doi.org/10.1016/j.brainres.2003.09.049 PMid:14642447
9. Setter S, Neumiller J, Dobbins E, Wood L, Clark J, DuVall C, Santiago A, Treatment of chorea associated with Huntington's disease: focus on tetrabenazine, Consul. Pharm, 2009; 24: 524-537. https://doi.org/10.4140/TCP.n.2009.524 PMid:19689181
10. Ahuja M, Bishnoi M, Chopra K, Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity, Toxicology, 2008; 244: 111-122. https://doi.org/10.1016/j.tox.2007.11.003 PMid:18164115
11. Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M, 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin, Can. J. Neurol. Sci, 1991; 18: 492-498. https://doi.org/10.1017/S0317167100032212 PMid:1782616
12. Heim KE, Tagliaferro AR, Bobilya DJ, Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem, 2002; 14(10): 572-584.13. https://doi.org/10.1016/S0955-2863(02)00208-5 PMid:12550068
13. Agati G, Azzarello E, Pollastri S, Tattini M, Flavonoids as antioxidants in plants: Location and functional significance, Plant Science, 2012; 196: 67-76. https://doi.org/10.1016/j.plantsci.2012.07.014 PMid:23017900
14. Garg A, Garg S, Zaneveld LJD, Singla AK, Chemistry and pharmacology of the citrus bioflavonoid hesperidin, Phytother Res, 2001;15:655-69. https://doi.org/10.1002/ptr.1074 PMid:11746857
15. Hwang SL, Yen GC, Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells, J Agric Food Chem, 2008;56:859-64. https://doi.org/10.1021/jf072826r PMid:18189359
16. Shepherd, J.K., Grewal, S.S., Fletcher, A., Bill, D.J., Dourish, C.T., 1994. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety, Psychopharmacol Berlin, 116: 56-64. https://doi.org/10.1007/BF02244871 PMid:7862931
17. X. Song, B. Zhou, P. Zhang, D. Lei, Y. Wang, G. Yao, T. Hayashi, M. Xia, S.I. Tashiro, S. Onodera, T. Ikejima, Protective effect of silibinin on learning and memory impairment in LPS-treated rats via ROS-BDNF-TrkB pathway, Neurochem. Res, 2016;41:1662-1672. https://doi.org/10.1007/s11064-016-1881-5 PMid:26961891
18. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Handubgham SJ, Functional assessments in mice and rats after focal stroke, Neuropharmacology, 2000; 39:806-816. https://doi.org/10.1016/S0028-3908(99)00262-2 PMid:10699446
19. Kulkarni SK, Hand Book of Experimental Pharmacology, Vallabh Prakashan, New Delhi, 1999.
20. Yan X, Wang S, Hou H, Ji R, Zhou J, Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia, Behav. Brain Res, 2007; 177: 282-289. https://doi.org/10.1016/j.bbr.2006.11.021 PMid:17210190
21. Song YN, Li HZ, Zhu JN, Guo CL, Wang JJ, Histamine improves rat rota-rod and balance beam performances through H2 receptors in the cerebellar interpositus nucleus, Neuroscience, 2006; 140:33-43. https://doi.org/10.1016/j.neuroscience.2006.01.045 PMid:16533576
22. Vis JC, Verbeek MM, Waal RM, Donkelaar HJ, Kremer HP, 3-nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum, Neuropath. Appl. Neuro, 1999; 25: 513-521. https://doi.org/10.1046/j.1365-2990.1999.00212.x PMid:10632901
23. Porsolt R.D., Bertin, A., Jalfre, M., Behavioral despair in mice: a primary screening test for antidepressants, Arch. Int. Pharmaco¬dyn. Ther, 1977; 229: 327-336.
24. Sandhir R, Mehrotra A, Kamboj SS, Lycopene prevents 3-nitropropionic acidinduced mitochondrial oxidative stress and dysfunctions in nervous system, Neurochem.Int,2010;57:579-587. https://doi.org/10.1016/j.neuint.2010.07.005 PMid:20643176
25. Marklund S, Marklund G, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur. J. Biochem, 1974;47: 469-474. https://doi.org/10.1111/j.1432-1033.1974.tb03714.x PMid:4215654
26. Claiborne A, Catalase activities, in: R.A. Greenwald (Ed.), CRC Handbook of Methods in Oxygen Radical Research, CRC Press, Boca Raton, 1985.
27. Gelvan D, Saltman P, Different cellular targets of Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbiturate acid assay, Biochim. Biophys. Acta, 1990; 1035: 353-360. https://doi.org/10.1016/0304-4165(90)90100-B
28. Kumar P, Kumar A, Effect of lycopene and epigallocatechin-3- gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism, Food Chem Toxicol, 2009; 47:2522-2530. https://doi.org/10.1016/j.fct.2009.07.011 PMid:19616597
29. King TE, Preparation of succinate dehydrogenase and reconstitution of succinate oxidase Method, Enzymol, 1967;10: 322-331. https://doi.org/10.1016/0076-6879(67)10061-X
30. Ellman GL, Courtney KD, Andres V, Featherstone RM, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol, 1961; 7: 88-95. https://doi.org/10.1016/0006-2952(61)90145-9 PMid:13726518
31. Kola PK, Akula A, Nissankara Rao LS, Danduga RC, Protective effect of naringin on pentylenetetrazole (PTZ)-induced kindling; possible mechanisms of antikindling, memory improvement, and neuroprotection, Epilepsy Behavi, 2017;72: 114-126. https://doi.org/10.1016/j.yebeh.2017.07.011 PMid:28846920
32. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM, Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats, Stroke 1986;17: 1304-1308. https://doi.org/10.1161/01.STR.17.6.1304 PMid:2433817
33. Ramaswamy S, McBride JL, Kordower JH, et al, Animal models of Huntington's disease, ILAR J, 2007;48:356-373. https://doi.org/10.1093/ilar.48.4.356 PMid:17712222
34. Kumar P, Kumar A, Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease, J Med Food, 2009;12: 591-600. https://doi.org/10.1089/jmf.2008.0028 PMid:19627208
35. Lagoa R, Lopez-Sanchez C, Samhan-Arias AK, Ganan CM, Garcia-Martinez V, Gutierrez-Merino C, Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid, J Neurochem, 2009; 111:473-487. https://doi.org/10.1111/j.1471-4159.2009.06331.x PMid:19682208
36. Kumar P, Kumar A, Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide, Behav Brain Res, 2010; 206:38-46. https://doi.org/10.1016/j.bbr.2009.08.028 PMid:19716383
37. Kumar P, Kumar A, Possible role of sertraline against 3- nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain, Prog Neuropsychopharmacol Biol Psychiatry, 2009;33:100-108. https://doi.org/10.1016/j.pnpbp.2008.10.013 PMid:19022325
38. Binienda ZK, Ali SA, Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity, Toxicol Lett, 2001; 125:67-73. https://doi.org/10.1016/S0378-4274(01)00415-5 PMid:11701224
39. Tadros MG, Khalifa AE, Abdel-Naim AB, Arafa HM, Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype, Pharmacol Biochem Behav, 2005; 82:574-582. https://doi.org/10.1016/j.pbb.2005.10.018 PMid:16337998
40. Kumar P, Padi SS, Naidu PS, Kumar A, Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioral changes: possible neuroprotective mechanisms, Behav Pharmacol, 2006;17:485-492. https://doi.org/10.1097/00008877-200609000-00014 PMid:16940769
41. S.H. Li, Z.X. Yu, C.L. Li, H.P. Nguyen, Y.X. Zhou, C. Deng, X.J. Li, Lack of huntingtin- associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease, J. Neurosci, 2003; 23: 6956-6964. https://doi.org/10.1523/JNEUROSCI.23-17-06956.2003 PMid:12890790 PMCid:PMC6740731
42. Guyot MC, Palfi S, Stutzmann JM, Maziere M, Hantraye P, Brouillet E, Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats, Neuroscience, 1997; 81: 141-149. https://doi.org/10.1016/S0306-4522(97)00192-9 PMid:9300407
43. Silva RH, Ablio VC, Kameda SR, et al, Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice, Prog Neuropsychopharmacol Biol Psychiatry, 2007;31:65-70. https://doi.org/10.1016/j.pnpbp.2006.06.019 PMid:16876303
44. Lee WT, Chang C, Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease, Prog Neurobiol, 2004; 72: 87-110. https://doi.org/10.1016/j.pneurobio.2004.02.002 PMid:15063527
Published
Abstract Display: 39 
PDF Downloads: 46 PDF Downloads: 3 How to Cite
Issue
Section
Copyright (c) 2024 Nagarjuna Babu Etukuri, Prameela Rani Avula
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.